Effect of Ivabradine on Heart Rate and Hemodynamics in Patients With Stage D Heart Failure (HF)/Cardiogenic Shock on Dobutamine Treatment
Phase of Trial: Phase IV
Latest Information Update: 22 May 2018
Price : $35 *
At a glance
- Drugs Ivabradine (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 09 May 2018 Status changed from not yet recruiting to recruiting.
- 28 Feb 2018 Planned initiation date changed from 1 Jan 2018 to 1 Mar 2018.